5 Einträge gefunden

1. Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians

   1. Gass, Paul
   2. Untch, Michael
   3. Müller, Volkmar
   4. Möbus, Volker
   5. Thomssen, Christoph
   6. Häberle, Lothar
   7. Erber, Ramona

   2018 - Forschungsinformationssystem des UKE
2. German adjuvant intergroup node-positive study:a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer

   1. von Minckwitz, Gunter
   2. Möbus, Volker
   3. Schneeweiss, Andreas
   4. Huober, Jens
   5. Thomssen, Christoph
   6. Untch, Michael
   7. Jackisch, Christian

   2013 - Forschungsinformationssystem des UKE
3. Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.

   1. Müller, Volkmar
   2. Thomssen, Christoph
   3. Schmidt, Marcus
   4. Glados, Manfred
   5. Jackisch, Christian
   6. Heilmann, Volker
   7. Hinke, Axel

   2010 - Forschungsinformationssystem des UKE - frei zugänglich
4. Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer.

   1. Konecny, Gottfried E
   2. Pauletti, Giovanni
   3. Untch, Michael
   4. Wang, He-Jing
   5. Möbus, Volker
   6. Kuhn, Walther
   7. Thomssen, Christoph

   2010 - Forschungsinformationssystem des UKE
5. Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.

   1. Untch, Michael
   2. Möbus, Volker
   3. Kuhn, Walther
   4. Muck, Bernd Rudolph
   5. Thomssen, Christoph
   6. Bauerfeind, Ingo
   7. Harbeck, Nadia

   2009 - Forschungsinformationssystem des UKE